Treasury Yields Hit Multi-Year Highs: ETFs to Gain

Treasury yields hit multi-year highs as Fed rate hike expectations, oil prices and fiscal concerns weigh on bonds. Explore ETFs positioned for rising rates.

Zacks Investment Research • Sep 15, 2026

Bond Vigilantes Smell Blood In The Water

Treasury Secretary Bessent insists on challenging the bond vigilantes, and neither side is backing down. The underlying trends are pointing toward volatility ahead and potentially much more.

Seeking Alpha • Sep 15, 2026

TMV: An Effective Interest Rate Hedge, And Leveraged ETF Watchlist.

The Direxion Daily 20+ Year Treasury Bear 3X ETF offers -3X daily leverage on long-term Treasuries, making it a popular trading and hedging instrument. TMV's long-term drift is historically positive, benefiting from trending rate environments, but it can suffer decay during sideways markets due to beta-slippage. Since January 2022, TMV has gained 230.8% as rates surged, demonstrating its effectiveness as an interest rate hedge for fixed-income portfolios.

Seeking Alpha • Sep 4, 2026

Inverse Treasury ETFs Likely to Shine Amid Rising Bond Yields

Rising oil prices, inflation fears and higher Treasury yields are creating a favorable backdrop for inverse Treasury ETFs.

Zacks Investment Research • Aug 18, 2026

Market Brief: The Quarter's Most Pivotal 48 Hours

On Wednesday, July 29, the FOMC rate decision will be followed by Microsoft and Meta earnings after the close. Thursday begins with the advance estimate of Q2 GDP and the June PCE inflation report before Apple and Amazon report after the bell. CME FedWatch currently implies a 62–65% probability that the Fed holds rates in July, with the remaining probability assigned to a hike.

Seeking Alpha • Jul 28, 2026

Yields Rise on Middle East Crisis: Inverse Treasury ETFs to Buy

Treasury yields climbed as Middle East tensions linger. These inverse Treasury ETFs could benefit if inflation and bond yields keep rising.

Zacks Investment Research • Jul 22, 2026

Weave Bio Expands Strategic Advisory Board with Two Former FDA Leaders

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, a leader in AI-native regulatory automation for drug development, today announced the expansion of its Strategic Advisory Board (SAB) with the appointment of two former U.S. Food and Drug Administration leaders, Tala Fakhouri, Ph.D., M.P.H. chief AI and regulatory strategy officer at Parexel, and Sean Khozin, M.D., M.P.H., chief executive officer of the CEO Roundtable on Cancer and Project Data Sphere. Their appointments give the company firsthand insi.

Business Wire • Jul 16, 2026

Treasury Yields Climb as Middle East Tensions Escalate: ETFs to Gain

Treasury yields surge as U.S.-Iran tensions lift oil prices. These ETFs could help investors navigate a rising-rate environment.

Zacks Investment Research • Jul 9, 2026

Rate Hike Risks Are Rife? ETF Strategies to Play

Rising inflation and hawkish Fed signals are reviving rate-hike fears. These ETFs may help investors navigate a higher-yield environment.

Zacks Investment Research • Jun 8, 2026

TMV: The S&P 500 Crash Hedge No One's Talking About, Until Now

Inverse, leveraged ETFs like the Direxion Daily 20+ Year Treasury Bear 3x ETF can effectively protect a bond ladder from inflation and rising interest rates. Many investors focus heavily on speculative growth stocks while missing rare, low-risk opportunities in bond ladders. Mid-2026 is an ideal time to build a US Treasury bond ladder to lock in stable, multi-decade returns.

Seeking Alpha • Jun 2, 2026